The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Prognostic Factors in Pancreatic Endocrine Neoplasms: An Analysis of 136 Cases With a Proposal for Low-Grade and Intermediate-Grade Groups
Abstract
PURPOSE: In some organs (eg, the lung), endocrine tumors are classified on the basis of mitotic rate and necrosis. The purpose of this study was to evaluate prognostic factors in pancreatic endocrine neoplasms recently treated at a single institution. PATIENTS AND METHODS: In 136 patients undergoing surgery from 1979 to 1998, the influence on disease-free survival (DFS) and disease-specific survival (DSS) of tumor size, mitotic rate, vascular invasion, necrosis, metastases, and nuclear grade was determined. Cases were further grouped according to an existing proposed classification system and then regrouped on the basis of mitotic rate (< 2 mitoses per 50 high-power fields v higher) and necrosis (present or absent) into low- and intermediate-grade groups. RESULTS: Correlations with DFS and DSS in univariate analysis included ≤ 2 mitoses per 50 high-power fields (P = .001, P = .002), vascular invasion (P = .02, P = .04), size ≤ 2 cm (P = .01, P = .05), metastases (P = .0002, P = .07), necrosis (P = .002, P = .16), and nuclear grade (P = .04, P = .33), respectively. By multivariate analysis, for DFS, tumor necrosis and presence of metastases retained significance (P = .01, P = .04, respectively). For DSS, only mitotic rate was a prognostic factor (P = .02). Among the 18 macroadenomas, eight borderline tumors, and 48 low-grade carcinomas, there was no significant difference in DSS between any groups (P = .3). However, in evaluating our newly proposed groups, the differences in DFS and DSS between low- and intermediate-grade groups were highly significant (P = .0007, P = .006, respectively). CONCLUSION: Pancreatic endocrine neoplasms exhibit a spectrum of biologic behavior, and the proposed benign (macroadenoma) and borderline groups contain potentially aggressive tumors. An alternative system based on mitotic rate and necrosis correlates strongly with survival without specifically designating any group as benign.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Travis, W. D., Linnoila, R. I., Tsokos, M. G., Hitchcock, C. L., Cutler, G. B., Nieman, L., Chrousos, G., Pass, H., & Doppman, J. (1991) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199106000-00003 · Cited by 880
Travis, W. D., Rush, W., Flieder, D. B., Falk, R., Fleming, M. V., Gal, A. A., & Koss, M. N. (1998) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199808000-00003 · Cited by 807
Pelosi, G., Bresaola, E., Bogina, G., Pasini, F., Rodella, S., Castelli, P., Iacono, C., Serio, G., & Zamboni, G. (1996) · Human Pathology · doi:10.1016/s0046-8177(96)90303-2 · Cited by 267
Islet cell carcinomas of the pancreas: a twenty-year experience.
Thompson, G. B., van Heerden, J. A., Grant, C. S., Carney, J. A., & Ilstrup, D. M. (1988) · PubMed · Cited by 249
Prognostic criteria in nonfunctioning pancreatic endocrine tumours
La Rosa, S., Capella, C., Sessa, F., Riva, C., Leone, B. E., Klersy, C., Rindi, G., & Solcia, E. (1996) · Virchows Archiv · doi:10.1007/bf00198436 · Cited by 246
Surgical experience with pancreatic and peripancreatic neuroendocrine tumors: review of 125 patients
Phan, G. Q., Yeo, C. J., Hruban, R. H., Lillemoe, K. D., Pitt, H. A., & Cameron, J. L. (1998) · Journal of Gastrointestinal Surgery · doi:10.1016/s1091-255x(98)80039-5 · Cited by 239
ISLET CELL TUMORS OF THE PANCREAS
Brentjens, R. J., & Saltz, L. B. (2001) · Surgical Clinics of North America · doi:10.1016/s0039-6109(05)70141-9 · Cited by 173
Broughan, T. A., Jd, L., Jm, S., & Hermann, R. E. (1986) · PubMed · Cited by 167
Rigaud, G., Missiaglia, E., Moore, P. S., Zamboni, G., Falconi, M., Talamini, G., Pesci, A., Baron, A., Lissandrini, D., Rindi, G., et al. (2001) · PubMed · Cited by 150
Islet Cell Carcinoma of the Pancreas
Lo, C. Y., van Heerden, J. A., Thompson, G. B., Grant, C. S., Søreide, J. A., & Harmsen, W. S. (1996) · World Journal of Surgery · doi:10.1007/s002689900134 · Cited by 137
Cited by
TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system
Rindi, G., Klöppel, G., Alhman, H., Caplin, M., Couvelard, A., de Herder, W. W., Erikssson, B., Falchetti, A., Falconi, M., Komminoth, P., et al. (2006) · Virchows Archiv · doi:10.1007/s00428-006-0250-1 · Cited by 1,547
Klimstra, D. S., Modlin, I. R., Coppola, D., Lloyd, R. V., & Suster, S. (2010) · Pancreas · doi:10.1097/mpa.0b013e3181ec124e · Cited by 1,072
Self-citationGastrointestinal Neuroendocrine Tumors: Pancreatic Endocrine Tumors
Metz, D. C., & Jensen, R. T. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.05.047 · Cited by 816
Neuroendocrine and Adrenal Tumors, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
Shah, M. H., Goldner, W. S., Benson, A. B., Bergsland, E., Blaszkowsky, L. S., Brock, P., Chan, J., Das, S., Dickson, P. V., Fanta, P., et al. (2021) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2021.0032 · Cited by 619
Kouvaraki, M. A., Ajani, J. A., Hoff, P., Wolff, R., Evans, D. B., Lozano, R., & Yao, J. C. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.04.024 · Cited by 607
NANETS Treatment Guidelines: Well-Differentiated Neuroendocrine Tumors of the Stomach and Pancreas
Kulke, M. H., Anthony, L. B., Bushnell, D. L., de Herder, W. W., Goldsmith, S. J., Klimstra, D. S., Marx, S. J., Pasieka, J. L., Pommier, R. F., Yao, J. C., et al. (2010) · Pancreas · doi:10.1097/mpa.0b013e3181ebb168 · Cited by 574
Self-citationDistinct roles for cysteine cathepsin genes in multistage tumorigenesis
Gocheva, V., Zeng, W., Ke, D., Klimstra, D., Reinheckel, T., Peters, C., Hanahan, D., & Joyce, J. A. (2006) · Genes & Development · doi:10.1101/gad.1407406 · Cited by 570
Self-citationFalconi, M., Bartsch, D. K., Eriksson, B., Klöppel, G., Lopes, J. M., O'Connor, J. M., Salazar, R., Taal, B. G., Vullierme, M. P., & O'Toole, D. (2012) · Neuroendocrinology · doi:10.1159/000335587 · Cited by 526
Pape, U., Jann, H., Müller‐Nordhorn, J., Bockelbrink, A., Berndt, U., Willich, S. N., Koch, M., Röcken, C., Rindi, G., & Wiedenmann, B. (2008) · Cancer · doi:10.1002/cncr.23549 · Cited by 405
Howe, J. R., Merchant, N. B., Conrad, C., Keutgen, X. M., Hallet, J., Drebin, J. A., Minter, R. M., Lairmore, T. C., Tseng, J. F., Zeh, H. J., et al. (2020) · Pancreas · doi:10.1097/mpa.0000000000001454 · Cited by 396
Panzuto, F., Nasoni, S., Falconi, M., Corleto, V. D., Capurso, G., Cassetta, S., Di Fonzo, M., Tornatore, V., Milione, M., Angeletti, S., et al. (2005) · Endocrine-Related Cancer · doi:10.1677/erc.1.01017 · Cited by 391
Prognostic factors of long-term outcome in gastroenteropancreatic neuroendocrine tumours
Pape, U.-F., Berndt, U., Muller-Nordhorn, J., Bohmig, M., Roll, S., Koch, M., Willich, S. N., & Wiedenmann, B. (2008) · Endocrine Related Cancer · doi:10.1677/erc-08-0017 · Cited by 384
Pancreatic endocrine neoplasms: epidemiology and prognosis of pancreatic endocrine tumors
Halfdanarson, T. R., Rubin, J., Farnell, M. B., Grant, C. S., & Petersen, G. M. (2008) · Endocrine Related Cancer · doi:10.1677/erc-07-0221 · Cited by 372
Ekeblad, S., Skogseid, B., Dunder, K., Öberg, K., & Eriksson, B. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0734 · Cited by 360
Tumor size correlates with malignancy in nonfunctioning pancreatic endocrine tumor
Bettini, R., Partelli, S., Boninsegna, L., Capelli, P., Crippa, S., Pederzoli, P., Scarpa, A., & Falconi, M. (2011) · Surgery · doi:10.1016/j.surg.2011.02.022 · Cited by 358
Tang, L. H., Untch, B. R., Reidy, D. L., O'Reilly, E., Dhall, D., Jih, L., Basturk, O., Allen, P. J., & Klimstra, D. S. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-0548 · Cited by 352
Self-citationKlimstra, D. S., Modlin, I. R., Adsay, N. V., Chetty, R., Deshpande, V., Gönen, M., Jensen, R. T., Kidd, M., Kulke, M. H., Lloyd, R. V., et al. (2010) · American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3181ce1447 · Cited by 351
Self-citationBilimoria, K. Y., Talamonti, M. S., Tomlinson, J. S., Stewart, A. K., Winchester, D. P., Ko, C. Y., & Bentrem, D. J. (2008) · Annals of Surgery · doi:10.1097/sla.0b013e31815b9cae · Cited by 341
Jann, H., Roll, S., Couvelard, A., Hentic, O., Pavel, M., Müller‐Nordhorn, J., Koch, M., Röcken, C., Rindi, G., Ruszniewski, P., et al. (2011) · Cancer · doi:10.1002/cncr.25855 · Cited by 289
Basturk, O., Tang, L., Hruban, R. H., Adsay, V., Yang, Z., Krasinskas, A. M., Vakiani, E., La Rosa, S., Jang, K.-T., Frankel, W. L., et al. (2014) · American Journal of Surgical Pathology · doi:10.1097/pas.0000000000000169 · Cited by 258
Self-citationCouvelard, A., O'Toole, D., Turley, H., Leek, R., Sauvanet, A., Degott, C., Ruszniewski, P., Belghiti, J., Harris, A. L., Gatter, K., et al. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602245 · Cited by 257
Neuroendocrine Tumors of the Pancreas
Ehehalt, F., Saeger, H. D., Schmidt, C. M., & Grützmann, R. (2009) · The Oncologist · doi:10.1634/theoncologist.2008-0259 · Cited by 255
Nikfarjam, M., Warshaw, A. L., Axelrod, L., Deshpande, V., Thayer, S. P., Ferrone, C. R., & Fernández-del Castillo, C. (2008) · Annals of Surgery · doi:10.1097/sla.0b013e31815792ed · Cited by 221
Hansel, D. E., Rahman, A., House, M., Ashfaq, R., Berg, K., Yeo, C. J., & Maitra, A. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0285 · Cited by 164
Metadata
- Authors
- Hochwald, S. N., Zee, S., Conlon, K. C., Colleoni, R., Louie, O., Brennan, M. F., & Klimstra, D. S.
- Venue
- Journal of Clinical Oncology
- Published
- 2002-06-01
- Volume
- 20
- Issue
- 11
- Pages
- 2633-2642
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2000987172
- Cited by
- 397
- References
- 11
- FWCI
- 6.65
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.